Back
Cimpress PLC 10K Form
Buy
60
CMPR
Cimpress PLC
Last Price:
68.08
Seasonality Move:
4.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-01-28 | 10Q | CMPR/Cimpress PLC Quarterly |
2020-10-29 | 10Q | CMPR/Cimpress PLC Quarterly |
2020-08-11 | 10K | CMPR/Cimpress PLC Annual |
2020-05-06 | 10Q | CMPR/Cimpress PLC Quarterly |
2020-01-30 | 10Q | CMPR/Cimpress PLC Quarterly |
2019-10-31 | 10Q | CMPR/Cimpress PLC Quarterly |
Receive CMPR News And Ratings
See the #1 stock for the next 7 days that we like better than CMPR
CMPR Financial Statistics
Sales & Book Value
Annual Sales: | $3.08B |
---|---|
Cash Flow: | $31.92M |
Price / Cash Flow: | 95.61 |
Annual Sales: | $-23.65 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -7.08000 |
---|---|
Net Income (TTM): | $-185.98M |
Gross Margin: | $1.44B |
Return on Equity: | 0% |
Return on Assets: | -9.33% |
Cimpress PLC Earnings Forecast
Key Cimpress PLC Financial Ratios
- The Gross Profit Margin over the past 23 years for CMPR is 46.73%.
- The Selling, General & Administrative Expenses for CMPR have been equal to 31.93% of Gross Profit Margin.
- The Research & Development expenses have been 9.81% of Revenue.
- The Interest Expense is -60.65% of Operating Income.
- The Net Earning history of CMPR is -6.04% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 14 years.
Cimpress PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Advertising Agencies |
Sector: | Communication Services |
Current Symbol: | CMPR |
CUSIP: | N20146 |
Website: | cimpress.com |
Debt
Debt-to-Equity Ratio: | -2.63 |
---|---|
Current Ratio: | 0.68 |
Quick Ratio: | 0.37 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CMPR Technical Analysis vs Fundamental Analysis
Buy
60
Cimpress PLC (CMPR)
is a Buy
Is Cimpress PLC a Buy or a Sell?
-
Cimpress PLC stock is rated a Buy
The current Cimpress PLC [CMPR] share price is $68.21. The Score for CMPR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.